Zhang N, Zhu L, Zhang Y, et al. Circulating Rather Than Alveolar Extracellular DNA Levels Predict Outcomes in Influenza. J Infect Dis. 2020;jiaa241
Background: High levels of circulating neutrophil extracellular traps (NETs) are associated with a poor prognosis in influenza A infection. It remains unclear whether NETs in the plasma or bronchoalveolar lavage fluid (BALF) can predict clinical outcomes in influenza.
Methods: One hundred eighteen patients who were diagnosed with H1N1 influenza in 2017-2018 were recruited. NETs were assessed in plasma and BALF samples by quantifying cell-free DNA (cfDNA) and protein-DNA complexes. Predictions of severe illness and 60-day mortality were analyzed with receiver operating characteristic curves.
Results: The NET levels were significantly elevated in the BALF and contributed to the pathology of lungs, yet it was not associated with disease severity or mortality in patients severely infected with H1N1. Plasma NET levels were significantly increased in the patients with severe influenza and positively correlated with the oxygen index and sequential organ failure assessment scores. High levels of plasma cfDNA (> 286.6 ng/ml) or histone-bound DNA (> 9.4 ng/ml) discriminated severe influenza from mild, and even higher levels of cfDNA (> 306.3 ng/ml) or histone-bound DNA (> 23.1 ng/ml) predicted fatal outcomes in severely ill patients.
Conclusions: The cfDNA and histone-bound DNA in plasma represent early predictive biomarkers for the prognosis of influenza.
Methods: One hundred eighteen patients who were diagnosed with H1N1 influenza in 2017-2018 were recruited. NETs were assessed in plasma and BALF samples by quantifying cell-free DNA (cfDNA) and protein-DNA complexes. Predictions of severe illness and 60-day mortality were analyzed with receiver operating characteristic curves.
Results: The NET levels were significantly elevated in the BALF and contributed to the pathology of lungs, yet it was not associated with disease severity or mortality in patients severely infected with H1N1. Plasma NET levels were significantly increased in the patients with severe influenza and positively correlated with the oxygen index and sequential organ failure assessment scores. High levels of plasma cfDNA (> 286.6 ng/ml) or histone-bound DNA (> 9.4 ng/ml) discriminated severe influenza from mild, and even higher levels of cfDNA (> 306.3 ng/ml) or histone-bound DNA (> 23.1 ng/ml) predicted fatal outcomes in severely ill patients.
Conclusions: The cfDNA and histone-bound DNA in plasma represent early predictive biomarkers for the prognosis of influenza.
See Also:
Latest articles in those days:
- mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020 12 hours ago
- Clinical Characteristics of 118 Pediatric Patients With Acute Benign Myositis Associated With Influenza A Virus Infection 12 hours ago
- Avian Influenza A Viruses Modulate the Cellular Cytoskeleton during Infection of Mammalian Hosts 12 hours ago
- Seroprevalence of Avian Influenza A(H5N6) Virus Infection, Guangdong Province, China, 2022 3 days ago
- Clinical Presentation, Risk Factors, and Comparison of Laboratory Diagnostics for Seasonal Influenza Virus Among Cambodians From 2007 to 2020 3 days ago
[Go Top] [Close Window]